Mirati Therapeutics, Inc.

Legal & General Group Plc

Report date

12/31/2023

Quarter

2023 Q4

Filed

5/29/2025

Shares

43,044

Value ($000)

2,529

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	5/29/2025	2,529	0.0%	43,044	12/31/2023
2023 Q3	11/14/2023	2,047	0.0%	46,985	9/30/2023
2023 Q2	8/14/2023	1,409	0.0%	38,991	6/30/2023
2023 Q1	5/15/2023	1,496	0.0%	40,235	3/31/2023
2022 Q4	2/14/2023	1,593	0.0%	35,159	12/31/2022
2022 Q3	11/14/2022	2,532	0.0%	36,255	9/30/2022
2022 Q2	8/22/2022	2,578	0.0%	38,397	6/30/2022
2022 Q1	5/16/2022	3,181	0.0%	38,691	3/31/2022
2021 Q4	2/14/2022	5,331	0.0%	36,338	12/31/2021
2021 Q3	11/15/2021	6,616	0.0%	37,401	9/30/2021
2021 Q2	8/12/2021	4,700	0.0%	29,095	6/30/2021
2021 Q1	5/17/2021	4,709	0.0%	27,487	3/31/2021
2020 Q4	2/12/2021	6,151	0.0%	28,001	12/31/2020
2020 Q3	11/13/2020	3,774	0.0%	22,723	9/30/2020
2020 Q2	8/14/2020	2,595	0.0%	22,728	6/30/2020
2020 Q1	5/14/2020	1,649	0.0%	21,450	3/31/2020
2019 Q4	2/13/2020	2,259	0.0%	17,530	12/31/2019